Anna K Younger, APRN | |
145 Innovation Dr, Jackson, TN 38305-3019 | |
(731) 422-0213 | |
(731) 660-8301 |
Full Name | Anna K Younger |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 5 Years |
Location | 145 Innovation Dr, Jackson, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013550839 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | 26835 (Tennessee) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Jackson Clinic Pa | 2668376872 | 176 |
News Archive
With a $500,000 Research Grant from Alliance for Cancer Gene Therapy, Sidi Chen, PhD, assistant professor in the Department of Genetics and Systems Biology Institute at Yale School of Medicine and member of Yale Cancer Center, will advance a versatile and highly scalable strategy he's been developing and calling MAEGI - Multiplexed Activation of Endogenous Genes as an Immunotherapy.
Researchers at the Universidad Politécnica de Madrid have found that regular and supervised exercise by experts during pregnancy can reduce the rate of instrumental and cesarean deliveries in healthy pregnant women.
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.
In a letter submitted today to the U.S. Food and Drug Administration (FDA), the National Organization for Rare Disorders (NORD) urged Commissioner Margaret Hamburg to give serious consideration to the concerns of the rare disease community when setting policy regarding official names for biologics, including biosimilars.
› Verified 6 days ago
Entity Name | Jackson Clinic Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285629386 PECOS PAC ID: 2668376872 Enrollment ID: O20040318000962 |
News Archive
With a $500,000 Research Grant from Alliance for Cancer Gene Therapy, Sidi Chen, PhD, assistant professor in the Department of Genetics and Systems Biology Institute at Yale School of Medicine and member of Yale Cancer Center, will advance a versatile and highly scalable strategy he's been developing and calling MAEGI - Multiplexed Activation of Endogenous Genes as an Immunotherapy.
Researchers at the Universidad Politécnica de Madrid have found that regular and supervised exercise by experts during pregnancy can reduce the rate of instrumental and cesarean deliveries in healthy pregnant women.
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.
In a letter submitted today to the U.S. Food and Drug Administration (FDA), the National Organization for Rare Disorders (NORD) urged Commissioner Margaret Hamburg to give serious consideration to the concerns of the rare disease community when setting policy regarding official names for biologics, including biosimilars.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Anna K Younger, APRN Po Box 400, Jackson, TN 38302-0400 Ph: (731) 425-5752 | Anna K Younger, APRN 145 Innovation Dr, Jackson, TN 38305-3019 Ph: (731) 422-0213 |
News Archive
With a $500,000 Research Grant from Alliance for Cancer Gene Therapy, Sidi Chen, PhD, assistant professor in the Department of Genetics and Systems Biology Institute at Yale School of Medicine and member of Yale Cancer Center, will advance a versatile and highly scalable strategy he's been developing and calling MAEGI - Multiplexed Activation of Endogenous Genes as an Immunotherapy.
Researchers at the Universidad Politécnica de Madrid have found that regular and supervised exercise by experts during pregnancy can reduce the rate of instrumental and cesarean deliveries in healthy pregnant women.
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.
In a letter submitted today to the U.S. Food and Drug Administration (FDA), the National Organization for Rare Disorders (NORD) urged Commissioner Margaret Hamburg to give serious consideration to the concerns of the rare disease community when setting policy regarding official names for biologics, including biosimilars.
› Verified 6 days ago
Katherine E Wyatt, A.P.R.N. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 145 Innovation Dr, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-660-8301 | |
Amy K Lawrence, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2863 Highway 45 Byp, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-660-8380 | |
Lauren Williams, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1047 Union University Dr, Jackson, TN 38305 Phone: 731-256-0035 | |
Kirsten Siler, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 27a Medical Center Drive, Jackson, TN 38301 Phone: 731-541-3310 | |
Stephanie Pool, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 36 Pemberton Cv, Jackson, TN 38305 Phone: 731-394-1145 Fax: 844-374-0233 | |
Kimberlie A Simpson, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 23 Independence Ln, Jackson, TN 38305 Phone: 731-617-1483 |